Platelet aggregation in patients with Moyamoya disease

Area of Science:

• Neuroscience
• Hematology
• Vascular Biology

Background:

• Moyamoya disease is a rare cerebrovascular disorder characterized by progressive stenosis of the internal carotid arteries.
• Altered platelet function may contribute to the pathophysiology of Moyamoya disease, potentially increasing thrombotic risk.

Purpose of the Study:

• To investigate platelet aggregation responses to common agonists in patients diagnosed with Moyamoya disease.
• To compare platelet aggregation in Moyamoya disease patients with healthy controls.

Main Methods:

• Platelet aggregation was measured in 28 Moyamoya disease patients and 27 healthy controls using adenosine diphosphate (ADP) and adrenalin as agonists.
• Statistical analysis was performed to compare aggregation levels between groups and to assess the impact of age.

Main Results:

• Moyamoya disease patients demonstrated significantly increased platelet aggregation compared to controls when stimulated with specific concentrations of ADP (2 and 4 μM) and adrenalin (9.1 and 22.7 μM).
• The observed increases in platelet aggregation followed nondissociative patterns.
• No significant differences in platelet aggregation were found between younger (<20 years) and older (≥20 years) patient subgroups.

Conclusions:

• Patients with Moyamoya disease exhibit enhanced platelet aggregation, suggesting a potential role in disease progression or complications.
• These findings highlight altered platelet reactivity as a key feature of Moyamoya disease.
• Age does not appear to be a significant factor influencing platelet aggregation in Moyamoya disease patients within the studied age range.